Young James Emmett
SEC CIK 2050748 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | CFO | 49.7K | $163.5K | — | 5 | 2025-01-27 | 2025-05-19 |
Most active insiders at TLSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stansky Michael P | Dir | $3.01M | — |
| 2 | Szela Mary T | CEO, Pres, Dir | $227.8K | $79.4K |
| 3 | Wahlstrom Mats | Dir | $151.8K | — |
| 4 | Valle William | Dir | $125.0K | — |
| 5 | Gordon Gary B. | Dir | $64.6K | — |
| 6 | Patience David | CFO | $32.2K | — |
| 7 | Marshak Richard | Chief Commercial Off | — | $15.7K |
| 8 | Stevens Jennifer | Chief Regulatory Off | — | $14.5K |
| 9 | Devlin Jodi | Chief of Clinical Ops | — | $13.2K |
| 10 | Cox Bryan F. | Chief of Research | — | $13.1K |
Young James Emmett made no open-market trades at TLSI in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-21 | 2025-05-19 | TLSI | TriSalus Life Sciences, Inc. | Young James Emmett | CFO | A - Grant | $5.18 | +13.2K | 49.7K | +36% | +$68.2K | |
| 2025-02-19 | 2025-02-18 | TLSI | TriSalus Life Sciences, Inc. | Young James Emmett | CFO | A - Grant | $0.00 | +14.8K | 36.5K | +68% | $0 | |
| I | 2025-02-06 | 2025-02-05 | TLSI | TriSalus Life Sciences, Inc. | Young James Emmett | CFO | P - Purchase | $5.65 | +6,000 | 30.0K | +25% | +$33.9K |
| DI | 2025-01-29 | 2025-01-27 | TLSI | TriSalus Life Sciences, Inc. | Young James Emmett | CFO | P - Purchase | $5.40 | +24.0K | 24.0K | New | +$129.6K |
| D | 2025-01-29 | 2025-01-27 | TLSI | TriSalus Life Sciences, Inc. | Young James Emmett | CFO | A - Grant | $0.00 | +12.5K | 21.7K | +135% | $0 |
Purchase Sale Sale after option exercise All abbreviations